- Trials with a EudraCT protocol (470)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
470 result(s) found for: Clinical data management.
Displaying page 1 of 24.
EudraCT Number: 2021-005613-14 | Sponsor Protocol Number: REUM-2021-01 | Start Date*: 2023-03-13 |
Sponsor Name: | ||
Full Title: Immune-Related Rheumatological Adverse Events study. Data collection from patients with cancer to evaluate rheumatological adverse events in patients treated with immune-checkpoint inhibitors. | ||
Medical condition: Any cancer patients starting immune checkpoint inhibitor therapy (ICI-therapy). Any patient exhibiting a rheumatological immune-related adverse event (R-irAE). Patients with newly developed rheum... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001305-82 | Sponsor Protocol Number: IC3627/18 | Start Date*: 2019-05-16 |
Sponsor Name:Laura Perelló Moreno | ||
Full Title: Study on the advantages of local post-operative infiltration in forefoot surgery. | ||
Medical condition: management of postoperative pain in ambulatory foot surgery that allows the realization of immediate rehabilitation and better functional results and personal satisfaction | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-014982-16 | Sponsor Protocol Number: DIA002 | Start Date*: 2010-02-25 | |||||||||||
Sponsor Name:Wockhardt UK Limited | |||||||||||||
Full Title: An open label, single dose safety study of Diamorphine Hydrochloride Nasal Spray (0.1mg/kg) in children | |||||||||||||
Medical condition: The IMP is to be used as an analgesic for the relief of acute pain. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002169-23 | Sponsor Protocol Number: DRYCHILD | Start Date*: 2017-09-06 | |||||||||||
Sponsor Name:Søren Rittig | |||||||||||||
Full Title: The effect of clinical characterization of children with monosymptomatic nocturnal enuresis on the efficacy of desmopressin and alarm therapy. | |||||||||||||
Medical condition: Enuresis nocturna | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) BE (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002824-98 | Sponsor Protocol Number: ANE_HEPUNOX | Start Date*: 2016-10-20 | |||||||||||
Sponsor Name:Fundació Hospital Vall Hebron Institut de Recerca | |||||||||||||
Full Title: Comparison of three techniques in the management of the postoperatory acute pain, after a general anesthesia based on the control of the nociception. | |||||||||||||
Medical condition: Acute postoperative pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020510-29 | Sponsor Protocol Number: OTR1020 | Start Date*: 2010-10-08 | ||||||||||||||||
Sponsor Name:Purdue Pharma L.P. | ||||||||||||||||||
Full Title: An Open-label Study to Characterise the Pharmacokinetics and Safety of Oxycodone Hydrochloride q12h Controlled-Release Tablets (ORF) in Paediatric Patients Aged 6 to 16 Years Inclusive, Who Require... | ||||||||||||||||||
Medical condition: Post operative and non-surgical paediatric patients, expected to or must have moderate to severe pain requiring oral opioid analgesic treatment for at least 24 hours. Patients must be inpatient for... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) FI (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003167-38 | Sponsor Protocol Number: NL50643.09r.r4 | Start Date*: 2015-04-28 |
Sponsor Name:Radboudumc | ||
Full Title: 68Ga-NODAGA-exendin-4 PET/CT in patients with AHH - a prospective comparative evaluation of preoperative imaging Under the FP7 project Betacure (602812); Personalized diagnosis and treatment of hy... | ||
Medical condition: Adult endogenous hyperinsulinemic hypoglycemia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003764-45 | Sponsor Protocol Number: UOL0727 | Start Date*: 2020-02-14 |
Sponsor Name:University of Leicester | ||
Full Title: Multicentre, open-label, randomised controlled trial of early surfactant therapy versus expectant management in late preterm and early term infants with respiratory distress. | ||
Medical condition: Respiratory distress in neonates born at 34 to 38+6 weeks of gestation | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2010-021955-14 | Sponsor Protocol Number: BUP3030 | Start Date*: 2011-10-17 | ||||||||||||||||
Sponsor Name:Purdue Pharma L.P. | ||||||||||||||||||
Full Title: A Multicenter, Inpatient, Open-label Study to Characterize the Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Aged from Birth to 6 Years of Age... | ||||||||||||||||||
Medical condition: Acute moderate to severe pain requiring opioids for at least 24 hours in postoperative and prolonged endotracheal intubated patients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-003534-27 | Sponsor Protocol Number: CIGE025B1301 | Start Date*: 2016-02-16 |
Sponsor Name:Novartis Pharmaceuticals | ||
Full Title: A 24 Week, Open Label, Multi-center Evaluation of Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years) With Inadequately Controlled Allergic ... | ||
Medical condition: Allergic asthma | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2020-000121-37 | Sponsor Protocol Number: 2020-PSMA | Start Date*: 2020-06-09 | |||||||||||
Sponsor Name:CYCLOPHARMA | |||||||||||||
Full Title: A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer | |||||||||||||
Medical condition: Patients with histopathologically confirmed prostate adenocarcinoma per original diagnosis and subsequent definitive therapy, with first biochemical recurrence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Completed) BE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003803-39 | Sponsor Protocol Number: 11.0126 | Start Date*: 2012-08-08 |
Sponsor Name:St George's University of London | ||
Full Title: Pain management in osteoarthritis using the centrally acting analgesics duloxetine and pregabalin | ||
Medical condition: Hand osteoarthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-005095-18 | Sponsor Protocol Number: ICR-CTSU/2013/10041 | Start Date*: 2014-09-19 | |||||||||||
Sponsor Name:The Institute of Cancer Research | |||||||||||||
Full Title: A phase II randomised feasibility study of chemoresection and surgical management in low risk non muscle invasive bladder cancer. | |||||||||||||
Medical condition: Low risk non muscle invasive bladder cancer | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019360-36 | Sponsor Protocol Number: 10015LH-OPMS | Start Date*: 2010-05-26 |
Sponsor Name:Belfast Health and Social Care Trust | ||
Full Title: Pilot study of treatment of depression in refractory asthma | ||
Medical condition: Refractory Asthma Depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-003041-41 | Sponsor Protocol Number: 012507 | Start Date*: 2018-11-16 | |||||||||||||||||||||
Sponsor Name:Queen Mary University of London | |||||||||||||||||||||||
Full Title: A pragmatic pilot randomised controlled trial of Prothrombin Complex Concentrate (PCC) versus Fresh Frozen Plasma (FFP) in adult patients who are undergoing Heart Surgery | |||||||||||||||||||||||
Medical condition: Major bleeding during cardiac surgery not related to vitamin K antagonists | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-002564-27 | Sponsor Protocol Number: STH16037 | Start Date*: 2013-01-31 |
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | ||
Full Title: Pilot open study of testosterone replacement in non-alcoholic steatohepatitis | ||
Medical condition: Non alcoholic fatty liver disease (NAFLD) in men with low serum testosterone levels | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-003346-32 | Sponsor Protocol Number: ET-19-194 | Start Date*: 2020-04-07 |
Sponsor Name:Centre Léon Bérard | ||
Full Title: PREFAcE : Interest of PET-PSMA imaging potentiated by androgen blockade in patients with biological relapse or persistent biological disease of a localized prostatic adenocarcinoma after initial tr... | ||
Medical condition: Patient with Prostate Adenocarcinoma in biological relapse or in biological recurrent disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002802-21 | Sponsor Protocol Number: PRIMERA001 | Start Date*: 2020-12-18 | ||||||||||||||||
Sponsor Name:Erasmus Medical Center | ||||||||||||||||||
Full Title: PeRsonalIzed MEdicine in Rheumatoid Arthritis (PRIMERA trial): a multicenter, single-blinded, randomized controlled trial comparing usual care with a tailor-made approach | ||||||||||||||||||
Medical condition: Rheumatoid arthritis according to 2010 criteria | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002717-39 | Sponsor Protocol Number: 07OB004 | Start Date*: 2008-03-13 | |||||||||||
Sponsor Name:University of Nottingham | |||||||||||||
Full Title: Pilot study for a trial of ursodeoxycholic acid (UDCA) and/or early delivery for obstetric cholestasis | |||||||||||||
Medical condition: Obstetric cholestasis (OC) is a serious problem in pregnancy. It affects about 1 in 150 pregnancies, about 4500 women per year in the UK. Affected women develop severe itching and sometimes jaundic... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003187-20 | Sponsor Protocol Number: | Start Date*: 2015-05-21 |
Sponsor Name:Barts Health NHS Trust | ||
Full Title: A multicentre double-blind randomised controlled trial to assess the clinical- and cost-effectiveness of facet-joint injections in selected patients with non-specific low back pain: a feasibility s... | ||
Medical condition: Non-specific low back pain of more than three months' duration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
